Sarah Cannon Cancer Network
Jun 28, 2018 - 11:53am EDT
Sarah Cannon Research Institute – UK, Part of HCA Healthcare UK, announced today the European initiation of a Phase II clinical trial studying the effectiveness of TIL therapy in the treatment of patients facing metastatic melanoma.
https://sarahcannon.com/about/newsroom/sarah-cannon-research-institute-uk-offers-til-therapy-to-patients-with-metastatic-melanoma
Sarah Cannon Cancer Network
Jun 8, 2018 - 1:45pm EDT
Didn't get a chance to attend the #ASCO18 Annual Meeting? Check out this video of the latest cancer research insights from our experts! Read more at our blog: https://sarahcannon.com/blog/entry/sarah-cannon-at-asco-2018